CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

HPV test may offer "better protection" than smear test

British scientists have found that testing for human papillomavirus (HPV), the virus that causes most cases of cervical cancer, may be a more effective way of protecting women against the disease than the existing cervical smear test.


The UK's cervical cancer screening programme invites women between the ages of 25 and 60 to have a smear test at least every five years which looks for pre-cancerous changes in the cells of the cervix.

Experts are currently considering whether HPV testing should be made routinely available on the NHS for women with borderline smear tests to help determine whether they should have treatment for these cell changes.

Read the whole article at Cancer Research UK

16.5.2008 Cancer Research UK


Back